logo-loader
RNS
Prudential PLC

Prudential PLC - Transaction in Own Shares

RNS Number : 5297I
Prudential PLC
14 May 2025
 

Prudential plc

 

Transaction in own shares

 

Prudential plc (the "Company") announces today it has purchased the following number of its ordinary shares of 5 pence each through Barclays Capital Securities Limited ("Barclays") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's 2024 Annual General Meeting (the "Purchase"). The Purchase was effected in accordance with the agreement entered into with Barclays, as announced on 5 December 2024.

 

          Date of purchase: 13 May 2025

 

          Aggregate number of ordinary shares purchased: 260,000 (ISIN GB0007099541)

 

          Lowest price paid per share: GBP 8.6560

 

          Highest price paid per share: GBP 8.8600

 

          Average price paid per share: GBP 8.7721

 


The Company intends to cancel the purchased shares. Following the above transaction, the Company will have 2,604,297,215 shares in issue.

 

Therefore, the total number of voting rights in the Company will be 2,604,297,215 and this figure may be used by shareholders as the denominator when determining whether they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

All shares were purchased from Barclays as an on-exchange transaction subject to the rules of the London Stock Exchange and the Hong Kong Code on Share Buy-backs.

 


Schedule of Purchases:

 

        Issuer name: Prudential plc

 

        ISIN: GB0007099541

 

        Intermediary name: Barclays Capital Securities Limited

 

        Intermediary Code: BARCGB91

 

        Currency: GBP

 


Aggregated information:

 


Venue

Volume-weighted average price

Aggregated volume

Lowest price paid per share

Highest price paid per share

BATS

£8.7698

51,915

£8.7020

£8.8600

CHI-X

£8.7673

68,569

£8.6640

£8.8560

London Stock Exchange

£8.7767

66,476

£8.6560

£8.8580

Turquoise

£8.7705

53,409

£8.6680

£8.8560

Aquis

£8.7833

19,631

£8.6660

£8.8540




Disaggregated information:

 

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 (as it forms part of domestic law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018), a full breakdown of the individual trades made by the Barclays on behalf of the Company is available via the link below.

 

http://www.rns-pdf.londonstockexchange.com/rns/5297I_1-2025-5-13.pdf


 

This announcement will also be available on Prudential's website at:

 

LSE - Prudential plc

 

Additional information

 

About Prudential plc

 

Prudential plc provides life and health insurance and asset management in 24 markets across Asia and Africa. Prudential's mission is to be the most trusted partner and protector for this generation and generations to come, by providing simple and accessible financial and health solutions. The business has dual primary listings on the Stock Exchange of Hong Kong (2378) and the London Stock Exchange (PRU). It also has a secondary listing on the Singapore Stock Exchange (K6S) and a listing on the New York Stock Exchange (PUK) in the form of American Depositary Receipts. It is a constituent of the Hang Seng Composite Index and is also included for trading in the Shenzhen-Hong Kong Stock Connect programme and the Shanghai-Hong Kong Stock Connect programme.

 

Prudential is not affiliated in any manner with Prudential Financial, Inc. a company whose principal place of business is in the United States of America, nor with The Prudential Assurance Company Limited, a subsidiary of M&G plc, a company incorporated in the United Kingdom.

 

https://www.prudentialplc.com/

 

Contact

 


Media


Simon Kutner

+44 (0)7581 023260

Sonia Tsang

+852 5580 7525





Investors/Analysts


Patrick Bowes

+852 9611 2981

William Elderkin

+44 (0)20 3977 9215

Darwin Lam

+852 2918 6348





 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSEAXSDFEASEFA
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.

In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

Transaction in Own Shares

3 days, 15 hours ago

Transaction in Own Shares

1 week, 3 days ago

Director/PDMR Shareholding

1 week, 6 days ago

Admission to Trading

2 weeks, 2 days ago

Director/PDMR Shareholding

2 weeks, 2 days ago

Director/PDMR Shareholding

2 weeks, 2 days ago

4 min read